TG Therapeutics, Inc.: Form 10-K/A for the period ended Dec 31, 2023
Filed with the SEC on Aug 9, 2024 and accepted by EDGAR at Aug 9, 2024, 16:01 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001437749-24-025850. Last ingested by Listed: Oct 24, 2026, 15:01 ET. Listed shows no prices and gives no investment advice.